Unilever finalized its $1.2 billion acquisition of Grüns on June 1, 2026. It's the global FMCG giant's first acquisition since its food division merger agreement with McCormick — and a strong signal on where the supplement market is heading: functional gummies are overtaking traditional formats (capsules, powders) in consumer preference.
Key Takeaways
- Unilever acquires Grüns: $1.2B, finalized June 1, 2026
- Grüns: founded 2023, #1 greens supplement in the US, 1M+ customers, 10M gummies/day
- Distribution: Amazon, Target, Walmart, Costco, Sam's Club, Sprouts
- Market signal: major FMCG players are converging on functional supplements
Who Grüns is and why Unilever paid $1.2B
Grüns is a startup founded in 2023 — barely 3 years old at acquisition. It sells gummies made from plant ingredients and superfoods (vegetables, fruits, algae), designed to fill daily nutritional gaps without swallowing dozens of capsules.
The traction is remarkable: 1 million customers, 95,000+ five-star reviews, 10 million gummies shipped daily, and the #1 position in the US greens supplement category on Amazon and in retail. The valuation had reached $500 million in the 2025 Series B — Unilever paid a 2.4x premium on that figure.
What it says about the supplement market
The Grüns acquisition is part of a consolidation wave in wellness by major food and consumer groups. In 2026: Danone acquired Huel (functional nutrition), Herbalife acquired Bioniq (personalized nutrition), Function raised $298M at a $2.5B valuation. Barriers between traditional FMCG and supplements are collapsing.
Unilever's strategy is clear: with the food division sale to McCormick, the group is pivoting toward higher-growth, higher-margin segments — beauty, wellness, personal care. Grüns fits into the Beauty & Wellbeing division, alongside Dove, TIGI, and Paula's Choice.
Key takeaways
- Unilever paid $1.2B for Grüns — a 2.4x premium on the last known valuation ($500M Series B 2025).
- The gummy format is redefining the supplement market: adherence, perceived naturalness, mass-market accessibility.
- Wellness consolidation by FMCG is accelerating — premium independent brands are becoming strategic acquisition targets.
- For industry players: community quality (1M+ loyal customers) and data (10M gummies/day) are the assets that justify high valuations.